Literature DB >> 15996891

Cell biology of IL-7, a key lymphotrophin.

Qiong Jiang1, Wen Qing Li, Francesca B Aiello, Renata Mazzucchelli, Benyam Asefa, Annette R Khaled, Scott K Durum.   

Abstract

IL-7 is essential for the development and survival of T lymphocytes. This review is primarily from the perspective of the cell biology of the responding T cell. Beginning with IL-7 receptor structure and regulation, the major signaling pathways appear to be via PI3K and Stat5, although the requirement for either has yet to be verified by published knockout experiments. The proliferation pathway induced by IL-7 differs from conventional growth factors and is primarily through posttranslational regulation of p27, a Cdk inhibitor, and Cdc25a, a Cdk-activating phosphatase. The survival function of IL-7 is largely through maintaining a favorable balance of bcl-2 family members including Bcl-2 itself and Mcl-1 on the positive side, and Bax, Bad and Bim on the negative side. There are also some remarkable metabolic effects of IL-7 withdrawal. Studies of IL-7 receptor signaling have yet to turn up unique pathways, despite the unique requirement for IL-7 in T cell biology. There remain significant questions regarding IL-7 production and the major producing cells have yet to be fully characterized.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15996891     DOI: 10.1016/j.cytogfr.2005.05.004

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  135 in total

1.  Pulmonary delivery of interleukin-7 provides efficient and safe delivery to the aging immune system.

Authors:  Wayne A Mitchell; Aina Castells; Pierre Olivier Lang; Emmanuel Matas; Antonio Lapenna; Richard Aspinall
Journal:  Rejuvenation Res       Date:  2012-06-04       Impact factor: 4.663

2.  Detection of nuclear and membrane antigens by liquid-based cytology following long-term storage of d1 cells, karpas cells, and peripheral blood mononuclear cells.

Authors:  Roberta Zappacosta; Francesca B Aiello; Tommaso D'Antuono; Antonio D Procopio; Scott K Durum; Pio Conti; Sandra Rosini
Journal:  Ann Clin Lab Sci       Date:  2011       Impact factor: 1.256

Review 3.  Reversing T cell immunosenescence: why, who, and how.

Authors:  Pierre Olivier Lang; Sheila Govind; Richard Aspinall
Journal:  Age (Dordr)       Date:  2012-02-26

4.  Differential effects of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival.

Authors:  Timothy W Hand; Weiguo Cui; Yong Woo Jung; Esen Sefik; Nikhil S Joshi; Anmol Chandele; Ying Liu; Susan M Kaech
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-07       Impact factor: 11.205

5.  Stage-specific functions of E-proteins at the β-selection and T-cell receptor checkpoints during thymocyte development.

Authors:  Mary Elizabeth Jones; Yuan Zhuang
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

6.  The major isoforms of Bim contribute to distinct biological activities that govern the processes of autophagy and apoptosis in interleukin-7 dependent lymphocytes.

Authors:  Shannon M Ruppert; Wenqing Li; Ge Zhang; Adina L Carlson; Arati Limaye; Scott K Durum; Annette R Khaled
Journal:  Biochim Biophys Acta       Date:  2012-06-21

7.  Effect of Anti-IL-15 Administration on T Cell and NK Cell Homeostasis in Rhesus Macaques.

Authors:  Maren Q DeGottardi; Afam A Okoye; Mukta Vaidya; Aarthi Talla; Audrie L Konfe; Matthew D Reyes; Joseph A Clock; Derick M Duell; Alfred W Legasse; Amit Sabnis; Byung S Park; Michael K Axthelm; Jacob D Estes; Keith A Reiman; Rafick-Pierre Sekaly; Louis J Picker
Journal:  J Immunol       Date:  2016-07-18       Impact factor: 5.422

Review 8.  Interlinking interleukin-7.

Authors:  Christina Kittipatarin; Annette R Khaled
Journal:  Cytokine       Date:  2007-09-04       Impact factor: 3.861

9.  Genetic variants in IL2RA and IL7R affect multiple sclerosis disease risk and progression.

Authors:  Anthony L Traboulsee; Cecily Q Bernales; Jay P Ross; Joshua D Lee; A Dessa Sadovnick; Carles Vilariño-Güell
Journal:  Neurogenetics       Date:  2014-04-26       Impact factor: 2.660

Review 10.  Strategies for enhancing adoptive T-cell immunotherapy against solid tumors using engineered cytokine signaling and other modalities.

Authors:  Thomas Shum; Robert L Kruse; Cliona M Rooney
Journal:  Expert Opin Biol Ther       Date:  2018-05-14       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.